References
- Arndt-Jovin D. J., Jovin T. M. Analysis and sorting of living ceils according to deoxyribonucleic acid content. J. Histochem. Cytochem. 1977; 25: 585–589
- Brenan M., Parish C. R. Analysis of genetic control of lymphocyte positioning. Immunol. Cell Biol. 1987; 65: 495–504
- Crister E. S., First N. L. Use of a fluorescent stain for visualization of nuclear material in living oocytes and early embryos. Stain Technol. 1986; 61: 1–5
- Erba E., Ubezio P., Broggini M., Ponti M., D'Etalici M. DNA damage, cytotoxic effect and cell-cell perturbation of Hoechst 33342 on L1210 cells in vitro. Cytometry 1988; 9: 1–6
- Hilvig I., Gropp A. Staining of consecutive heterochromatin in mammalian chromosomes with a new fluorochrome. Exp. Cell Res. 1972; 75: 122–126
- Homori E., Arndt-Jovin D. J., Grimwade B. G., Jovin T. M. Selection of viable cells with known DNA content. Cytometry 1980; 1: 132–135
- Hosino T., Knebel K. D., Rosenblum M. L., Dougharty D. V., Wilson C. B. Clonogenicity of multiple populations of human glioma cells in vitro sorted by DNA content. Cancer 1982; 50: 997–1002
- Le Douarin N. M. Cell recognition based on natural morphological markers. Med. Biol. 1974; 52: 281–319
- Luttmer S. J., Longo F. L. Examination of living and fixed gametes and early embryos stained with supravital fluorochromes (Hoechst 33342 and 3,3′-dihexyloxacarbocyanine iodide). Gamete Res. 1986; 15: 267–283
- Muller W., Gautier F. Interactions of heteroaromatic compounds with nucleic acids. A-T specific non-intercalating DNA ligands. Eur. J. Biochem. 1975; 54: 385–394
- Olive P. L., Chaplin R. E., Durand R. E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Brit. J. Cancer 1985; 52: 739–746
- Sieniann D. W., Keng P. C. Cell cycle specific toxicity of Hoechst 33342 stain in untreated or irradiated murine tumour cells. Cancer Res. 1986; 46: 3556–3559
- Smith K. A., Hill S. A., Begg A. C., Denekamp J. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. Brit. J. Cancer 1988; 57: 247–263